Aonong Group(SH:603363) Zheng Quan Zhi Xing·2025-08-27 10:16Core Viewpoint - The stock of Fujian Aonong Biological Technology Group Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative price deviation exceeding 20% over three consecutive trading days in August 2025 [1][2]. Group 1: Stock Trading Abnormality - The company's stock price increased by more than 20% cumulatively on August 25, 26, and 27, 2025, which is classified as an abnormal trading fluctuation according to the Shanghai Stock Exchange regulations [1][2]. - The company conducted a self-examination and confirmed that there are no undisclosed significant matters or information that could impact the stock price [1][2]. Group 2: Operational Status - The company reported that its production and operational status is normal, with no significant changes in its main business activities [1][2]. Group 3: Major Events and Market Influence - There are no undisclosed major events that could significantly affect the stock price, such as major asset restructuring, share issuance, or significant business collaborations [2]. - The company has not identified any media reports or market rumors that could have a substantial impact on its stock price [2]. Group 4: Insider Trading - The company confirmed that there were no stock trades by its controlling shareholders or senior management during the period of abnormal stock price fluctuation [2]. Group 5: Board Statement - The board of directors affirmed that there are no undisclosed matters that should be reported according to the Shanghai Stock Exchange listing rules, and previous disclosures do not require correction or supplementation [2].